These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15482815)

  • 1. Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration.
    Butterfield DA; Boyd-Kimball D
    Int Rev Neurobiol; 2004; 61():159-88. PubMed ID: 15482815
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.
    Lovestone S; Güntert A; Hye A; Lynham S; Thambisetty M; Ward M
    Expert Rev Proteomics; 2007 Apr; 4(2):227-38. PubMed ID: 17425458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics studies of traumatic brain injury.
    Wang KK; Ottens A; Haskins W; Liu MC; Kobeissy F; Denslow N; Chen S; Hayes RL
    Int Rev Neurobiol; 2004; 61():215-40. PubMed ID: 15482817
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain.
    Butterfield DA
    Brain Res; 2004 Mar; 1000(1-2):1-7. PubMed ID: 15053946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of proteomics in dementia and Alzheimer's disease.
    Zellner M; Veitinger M; Umlauf E
    Acta Neuropathol; 2009 Jul; 118(1):181-95. PubMed ID: 19259691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of proteomics to neurological diseases].
    Brea D; Cristobo I; Sobrino T; Rodríguez-González R; Mosquera E; Moldes O; Castillo J
    Neurologia; 2007 Apr; 22(3):170-9. PubMed ID: 17364255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
    Roe MR; Griffin TJ
    Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics analysis of human cerebrospinal fluid.
    Yuan X; Desiderio DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis.
    Sizova D; Charbaut E; Delalande F; Poirier F; High AA; Parker F; Van Dorsselaer A; Duchesne M; Diu-Hercend A
    Neurobiol Aging; 2007 Mar; 28(3):357-70. PubMed ID: 16519965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing proteomic expression in a clinical screening environment using mass spectrometry.
    Chace DH; Spitzer A
    Expert Rev Proteomics; 2005 Aug; 2(4):453-4. PubMed ID: 16097879
    [No Abstract]   [Full Text] [Related]  

  • 12. Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry.
    Wittmann-Liebold B; Graack HR; Pohl T
    Proteomics; 2006 Sep; 6(17):4688-703. PubMed ID: 16933336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
    Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of oxidatively modified proteins in Alzheimer's disease brain: insights into neurodegeneration.
    Butterfield DA; Castegna A
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):747-51. PubMed ID: 14528911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling of beta-cells using a classical approach - two-dimensional gel electrophoresis.
    Süss C; Solimena M
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S13-20. PubMed ID: 18777447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics with two-dimensional gel electrophoresis and mass spectrometry analysis in cardiovascular research.
    You SA; Wang QK
    Methods Mol Med; 2006; 129():15-26. PubMed ID: 17085802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and alcoholism.
    Witzmann FA; Strother WN
    Int Rev Neurobiol; 2004; 61():189-214. PubMed ID: 15482816
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease.
    Boyd-Kimball D; Poon HF; Lynn BC; Cai J; Pierce WM; Klein JB; Ferguson J; Link CD; Butterfield DA
    Neurobiol Aging; 2006 Sep; 27(9):1239-49. PubMed ID: 16099075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human skeletal muscle biopsy samples using shotgun proteomics.
    Parker KC; Walsh RJ; Salajegheh M; Amato AA; Krastins B; Sarracino DA; Greenberg SA
    J Proteome Res; 2009 Jul; 8(7):3265-77. PubMed ID: 19382779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome studies of CSF in AD patients.
    Davidsson P; Sjögren M
    Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.